Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion type Assertion NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_head.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion wasGeneratedBy ECO_0000203 NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_provenance.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion wasDerivedFrom befree-20140225 NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_provenance.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion SIO_000772 12566928 NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_provenance.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion evidence source_evidence_literature NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_provenance.
- NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_assertion description "[All MAPK pathways, i.e., the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 pathways, are activated in vulnerable neurons in patients with AD suggesting that MAPK pathways are involved in the pathophysiology and pathogenesis of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516840.RAKAZkJL1NCrpIW2-Ug2wGejKIoSXAuF_w8wF_ymwdFrE130_provenance.